hello all interesting ctix financing news: Cellceutix

New Post Public Reply Private Reply Replies (5) Message Board
umiak

hello all interesting ctix financing news:

Cellceutix Enters Into a $10 Million Common Stock Purchase Agreement With Aspire Capital Fund, LLC

BEVERLY, MA – December 10, 2012--Cellceutix Corporation (OTCBB: CTIX) (the "Company"), a clinical stage biopharmaceutical company focused on discovering small molecule drugs to treat unmet medical conditions, including drug-resistant cancers and autoimmune diseases, today announced that it has entered into a common stock purchase agreement (the “Purchase Agreement”) with Aspire Capital Fund, LLC (“Aspire”), an Illinois limited liability company. Aspire has committed to purchase up to $10 million of Cellceutix’s common stock over the next three years at prices based on the market price at the time of each sale. Cellceutix will use the net proceeds from the Purchase Agreement to advance the Company’s pipeline development, including, 

- The Phase 1 trial evaluating Kevetrin™ as a potential treatment for solid tumors which is currently underway at Harvard Cancer Center’s Dana-Farber Cancer Institute and partner Beth Israel Deacones Medical Center; and 

- The development of Prurisol™ (KM-133) for psoriasis, where Cellceutix has begun the preparatory work necessary for a Phase 2/3 clinical trial in 2013 following guidance from the U.S. Food and Drug Administration for a section 505(b)(2) designation for Prurisol. 

“We are very pleased to have reached this agreement under such favorable terms with Aspire,” says Leo Ehrlich, Chief Executive Officer of Cellceutix. “As we move forward in the clinical trials for Kevetrin and Prurisol, we plan to use the agreement with Aspire Capital to provide us access to funding as needed. It is this flexibility that the agreement allows us, as well as Aspire Capital’s excellent reputation as an investor, that leads us to believe that this will be a very successful long-term relationship.” 

“After visiting the Cellceutix headquarters and laboratory during our due diligence process, it was clear that it is a very impressive company,” commented Steven G. Martin, Managing Member of Aspire Capital. “What differentiates Cellceutix is the combination of having promising compounds and validation through collaboration with some of the world’s highest caliber medical research institutions. In addition, we believe Cellceutix has an experienced management team that can successfully advance the company’s programs, so we are very excited about this investment opportunity.” 


Key aspects of the Purchase Agreement include: 

- Cellceutix will control the timing and amount of any sales of common stock to Aspire Capital and will know the sales price before directing Aspire Capital to purchase shares. 

- Aspire Capital has no right to require any sales by the Company, but is obligated to make purchases as the Company directs, in accordance with the terms of the Purchase Agreement. 

- There are no limitations on use of proceeds, financial covenants, restrictions on future financings, rights of first refusal, participation rights, penalties or liquidated damages in the Purchase Agreement. 

- The Purchase Agreement may be terminated by Cellceutix at any time, at its discretion, without any additional cost or penalty. 
Cellceutix has issued to Aspire Capital additional common shares as consideration for entering into this agreement. 

A more complete and detailed description of the transaction is set forth in the Company's Current Report on Form 8-K, filed today with the U.S. Securities and Exchange Commission. 

About Cellceutix
Headquartered in Beverly, Massachusetts, Cellceutix is a publicly traded company under the symbol “CTIX”. It is an emerging bio-pharmaceutical company focused on the development of its pipeline of compounds targeting areas of unmet medical need. Our flagship compound, Kevetrin™, is an anti-cancer drug which has demonstrated the ability in pre-clinical studies to regulate the p53 pathway and attack cancers which have proven resistant to today’s cancer therapies (drug-resistant cancers). Cellceutix also owns the rights to seven other drug compounds, including KM-133, which is in development for psoriasis, and KM-391 for the treatment of the core symptoms of autism. More information is available on the Cellceutix web site at www.cellceutix.com. 

About Aspire Capital Fund, LLC
Aspire Capital Fund, LLC is an institutional investor based in Chicago, Illinois, with a fundamental investment approach. Aspire Capital invests in a wide range of companies and industries emphasizing life sciences, energy and technology. 

Safe Harbor Forward-Looking Statements

To the extent that statements in this press release are not strictly historical, including statements as to revenue projections, business strategy, outlook, objectives, future milestones, plans, intentions, goals, future financial conditions, future collaboration agreements, the success of the Company’s development, events conditioned on stockholder or other approval, or otherwise as to future events, such statements are forward-looking, and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. The forward-looking statements contained in this release are subject to certain risks and uncertainties that could cause actual results to differ materially from the statements made. Factors that may impact Cellceutix’s success are more fully disclosed in Cellceutix’s most recent public filings with the U.S. Securities and Exchange Commission. 

INVESTOR AND MEDIA CONTACT: 
Cellceutix Corp. 
Leo Ehrlich 
(978) 236-8717 
info@cellceutix.com 


Scroll down for more posts ▼

Top 10 Most Recent News Articles

RingConn Bets Middle-earth Fandom Can Boost Health Wearables

Updated Category News Views 73

A Familiar Gold Band Meets a Crowded Wearables Market RingConn has taken one of pop culture's most loaded objects and turned it into a health-tracking accessory, which is either clever brand work or a costly bit of cosplay depending on execution. The company unveiled The One Ring, a limited-edition version of its Gen 3 Smart Ring, through a partnership with Warner Bros....

Continue Reading
First Horizon Opens Its Charlotte Office in South End

Updated Category News Views 161

A Building Is Not a Balance Sheet Charlotte got a fresh First Horizon sign at 110 East Boulevard on Nov. 19, 2026, and that is a sensible move, not a magic trick. The bank has officially opened a corporate office in the city’s South End neighborhood, positioning the team to develop client relationships across the Charlotte area and broaden its regional footprint. That...

Continue Reading
New York's $1.2M Prison Abuse Deal Raises State Stakes

Updated Category News Views 41

One courtroom result can expose a whole warehouse of institutional neglect, and this one lands with a grim thud. New York has agreed to pay $1.2 million to resolve a claim involving sexual assault by a former corrections officer at Bayview Correctional Facility in Manhattan. The settlement came after a two-week Adult Survivors Act bellwether trial concluded on November 17...

Continue Reading
Sprocket’s GigaOm Leap Puts PTaaS Claims Under Scrutiny

Updated Category News Views 21

Security vendors love a shiny quadrant, but this one deserves more than the usual polite golf clap. Sprocket Security moved from Challenger and Outperformer in GigaOm’s 2025 Penetration Testing as a Service assessment to a Leader in the version 5 report released in 2026. That is a meaningful jump in a category where buyers are tired of annual testing reports that go...

Continue Reading
Perigon Builds Its Investment Bench for the Next Leg

Updated Category News Views 42

Perigon is rearranging the engine room before the next growth spurt gets noisy. The firm has named Christopher Broderick Director of Investments and Research, added two trading associates, and put another brick behind the broader operating structure Rafia Hasan has been assembling since taking on the chief operating officer role in August. That may sound like ordinary...

Continue Reading
Midea’s SC26 Cooling Pitch Targets AI Build Delays

Updated Category News Views 80

Heat is the uninvited partner in every AI build, and Midea is making a sensible argument that nobody gets paid for racks sitting idle while piping crews wrestle with a complicated cooling plant. At SC26 in Chicago, held November 17 through 19, the company made its North American debut for a modular prefabricated AI data-center cooling setup built around a magnetic coolant...

Continue Reading
HVAC’s $383.6 Billion Shift Is About More Than Units

Updated Category News Views 163

Server racks are turning cooling gear into a front-row industrial story, and that deserves more attention than the usual sleepy talk about replacement air conditioners. Frost & Sullivan projects the global HVAC equipment market will reach $383.6 billion by 2031, growing at a 7.0% compound annual rate from 2025. That is a sizable market, sure, but the more interesting...

Continue Reading
New York Gala Puts $3 Million Behind EB Research Work

Updated Category News Views 45

Three million dollars changes the temperature in a research room, even if it does not magically solve the hard part. EB Research Partnership said its New York gala raised more than $3 million, with Eddie Vedder, Hozier, Tom Holland and Colin Farrell among the names helping draw attention. For a nonprofit operating around research, that is not a fluffy society-page...

Continue Reading
RLX Revenue Soars, but European Margins Need Proof

Updated Category News Views 104

Revenue can wear a fancy suit while earnings arrive in work boots, and RLX Technology's third quarter is exactly that kind of report. The newly consolidated European distribution business pushed third-quarter revenue to RMB1.92 billion, up 69.7% year over year. That is a real jump, not pocket change. But the same acquisition also changed the mix, squeezed the blended...

Continue Reading
San Bernardino Teamsters Back Their Historic Contract

Updated Category News Views 0

A 90% vote does not whisper; it rattles the filing cabinets. More than 12,000 San Bernardino County members of Teamsters Local 1932 have ratified a new labor agreement with over 90% approval, according to the union’s November 20 announcement. In a public-sector negotiation, that kind of margin matters because it tells management the workforce is not merely accepting a...

Continue Reading

Top 5 Most Recently Viewed Articles

Celebrate the Festive Spirit with Jekyll Island Clubs' Events

Updated Category News Views 65

Experience the Magic of the Holiday Season at Jekyll Island If you’ve ever kept your Christmas lights up all year round or find yourself shopping for gifts as soon as summer ends, the Jekyll Island Club Resort is the place to be this holiday season. With festivities kicking off earlier each year, both the Jekyll Island Club and the adjoining Ocean Club are gearing up to...

Continue Reading
Uber-Lawyer Deal Balances Rights and Safety in CA

Updated Category News Views 51

California's Uber Compromise: Navigating a Tricky Landscape Holy moly, it looks like we've got ourselves a piece of legislation that tightrope-walks the chaos between Uber, Lyft, and the California ballot. This isn't just another boardroom drama—it's a real, messy tug-of-war that gets to the heart of what it means to keep riders safe without drowning in legal...

Continue Reading
Hurricane Milton's Devastating Potential: Stocks to Monitor

Updated Category News Views 128

Hurricane Milton’s Threat to Industries The looming arrival of Hurricane Milton poses significant risks to multiple sectors, including insurance, utilities, banking, and tourism. As it approaches Florida, analysts are focusing on how this storm could impact stocks and local economies. Hurricane Milton Update The storm has been officially downgraded to a Category 4 as it...

Continue Reading
Why Sports Betting Companies Face Major Challenges Ahead

Updated Category News Views 254

Understanding the Decline of Sports Betting Stocks Recently, the sports betting industry has seen significant stock declines, sparked by a combination of market downturns and regulatory setbacks. Investors have been on edge, especially considering the overall market turbulence characterized by a substantial drop in major indices. Companies like DraftKings and Flutter...

Continue Reading
Veterans Guardian Empowers Veterans with New Clinic Initiative

Updated Category News Views 177

Veterans Guardian Hosts Inaugural VA Disability Claims Assistance Clinic The Veterans Guardian and the Black Veterans Empowerment Council have recently taken a significant step in supporting veterans by organizing their first VA Disability Claims Assistance Clinic. This initiative aims to help veterans navigate the complex VA claims process, ensuring they access the...

Continue Reading